Hemant Kumar, Ph.D.
Senior Vice President, Manufacturing
Hemant Kumar joined AnaptysBio in November 2017 with more than 20 years of experience in biologicals manufacturing. Dr. Kumar was previously Global Head of Biologics Product Development at Merck Biologics & Vaccines, which followed his tenures at Sanofi Genzyme, Lonza Biologics, Sanofi Pasteur and Ortho/J&J. His product development experience spans GMP manufacturing and/or commercial launch of Orthoclone® OKT3, Procrit®, Remicade®, Lemtrada®, Praluent®, Dupixent®, Keytruda® and several other approved biologic products. Dr. Kumar received his Ph.D. in biochemistry from A.M. University in Aligarh, India and was a postdoctoral associate at Yale University School of Medicine.